SG Americas Securities, LLC
Broker-DealerPosition in TSHA — Taysha Gene Therapies, Inc.
CIK 1313360
NEW YORK, NY
Position in TSHA
as of Mar 31, 2026
· filed Apr 16, 2026
Position Value
$9,730,036
+$5,431,929 QoQ
Shares Held
2,176,742
+178.5% QoQ
Ownership
0.757%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SG Americas Securities, LLC holds $695,801,470 across 175 Biotechnology names. TSHA ranks #18 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
158,278 | $122,291,913 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
879,701 | $59,934,029 | |
| 3 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,018,174 | $56,529,053 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
199,705 | $37,754,230 | |
| 5 | URGN |
UroGen Pharma Ltd.
|
1,657,846 | $29,808,071 | |
| 6 | ASND |
Ascendis Pharma A/S
|
120,790 | $27,628,296 | |
| 7 | INCY |
Incyte Corp
|
285,152 | $26,838,506 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
56,982 | $25,444,742 |
All Filings in TSHA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,730,036 | 2,176,742 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $4,298,107 | 781,474 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $107,743 | 32,949 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $1,139,525 | 493,301 | Shares | Sole | 2025-08-08 | |
| 2024-12-31 | $49,301 | 28,498 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $128,607 | 63,984 | Shares | Sole | 2024-10-03 | |
| 2021-09-30 | $170,708 | 9,168 | Shares | Sole | 2021-11-01 | |
| No filing history on record for this holder in this stock. | ||||||